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Abstract
Background: The paper’s primary purpose is to determine changes in magnitude and causes of institutional maternal
mortality in Mozambique. We also describe shifts in the location of institutional deaths and changes in availability of
prevention and treatment measures for malaria and HIV infection.
Methods: Two national cross-sectional assessments of health facilities with childbirth services were conducted in 2007
and 2012. Each collected retrospective data on deliveries and maternal deaths and their causes. In 2007, 2,199 cases of
maternal deaths were documented over a 12 month period; in 2012, 459 cases were identified over a three month
period. In 2007, data collection also included reviews of maternal deaths when records were available (n = 712).
Results: Institutional maternal mortality declined from 541 to 284/100,000 births from 2007 to 2012. The rate of
decline among women dying of direct causes was 66 % compared to 26 % among women dying of indirect
causes. Cause-specific mortality ratios fell for all direct causes. Patterns among indirect causes were less conclusive
given differences in cause-of-death recording. In absolute numbers, the combination of antepartum and postpartum
hemorrhage was the leading direct cause of death each year and HIV and malaria the main non-obstetric causes.
Based on maternal death reviews, evidence of HIV infection, malaria or anemia was found in more than 40 % of
maternal deaths due to abortion, ectopic pregnancy and sepsis. Almost half (49 %) of all institutional maternal deaths
took place in the largest hospitals in 2007 while in 2012, only 24 % occurred in these hospitals. The availability of
antiretrovirals and antimalarials increased in all types of facilities, but increases were most dramatic in health centers.
Conclusions: The rate at which women died of direct causes in Mozambique’s health facilities appears to have declined
significantly. Despite a clear improvement in access to antiretrovirals and antimalarials, especially at lower levels of health
care, malaria, HIV, and anemia continue to exact a heavy toll on child-bearing women. Going forward, efforts to
end preventable maternal and newborn deaths must maximize the use of antenatal care that includes integrated
preventive/treatment options for HIV infection, malaria and anemia.
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Background
The east African country of Mozambique fits a paradigm
of obstetric transition where maternal mortality and
fertility remain high, and access to care and health sys-
tem infrastructure continue to be a challenge. These
characteristics define Stage 2 of the obstetric transition,
where direct causes of maternal mortality predominate
but a sizeable number of deaths are linked to infectious
diseases [1]. It is also a country where the demand for
maternity services is well-established and increasing [2].
Indirect maternal deaths are linked to previously
existing diseases that are aggravated during pregnancy,
or to diseases developed during pregnancy but are not
due to direct obstetric causes [3]. They account for
27.5 % of maternal deaths worldwide according to the
most recent systematic review for 2003–09; the per-
centage in sub-Saharan Africa is 28.6 % [4]. Both the
first systematic review (1998–2002) and the 2003–2009
review highlighted the importance of indirect deaths in
sub-Saharan Africa [5].
Women of reproductive age in Mozambique face a
sobering circle of risk when they become pregnant—an
increased risk of malaria, and of HIV infection and
transmission. If a woman is HIV-infected, she is at
increased risk of malaria complications, including severe
anemia and maternal death, and complications for the
child. These risks are in addition to the well-known
obstetric risks faced by every woman who becomes preg-
nant [6]. HIV-infection in pregnancy increases the risk
of maternal death by about eight times as well as the
odds of developing certain obstetric complications such
as intrauterine infections [7–9]. Infectious diseases can
be prevented or treated and anemia can be reduced if
not eliminated when women attend antenatal services
able to address these problems. Antenatal care also pro-
vides the opportunity to detect and treat hypertensive
diseases and infections, while a skilled professional at
birth and emergency medical back up services should
address the obstetric threats.
According to the 2013 estimates from WHO, UNICEF,
UNFPA and the World Bank, Mozambique is “making
progress” towards achieving the Millennium Develop-
ment Goal (MDG) for improving maternal health; the
maternal mortality ratio (MMR) currently stands at 480/
100,000 live births. Between 1990 and 2013, the average
annual decline in the MMR was 4.3 %, amounting to a
64 % decline since 1990, only 11 percentage points shy
of achieving the 75 % reduction called for by the MDG 5
[3]. The percentage of facility births has increased from
47 % to 55 % according to the 2003 and 2011
Mozambique Demographic and Health Surveys [10, 11].
Sub-Saharan Africa accounts for 62 % of global maternal
deaths as well as 91 % of the maternal deaths attributed
to HIV/AIDS [3]. The contribution of HIV/AIDS to
pregnancy-related mortality in this region has been
estimated to be as much as 50 %, where the prevalence
of HIV is 15 % or higher, and as low as 3 % [8, 12].
Measurement of attribution is clouded with concerns over
the lack of standard approaches and when HIV should be
considered an indirect cause or a coincidental cause [12].
The Mozambique 2007–2008 Post-Census Mortality
Verbal Autopsy (INCAM) study estimated that HIV was
the second leading cause of death in the general popula-
tion [13]. Based on these data Singh et al. estimated that
18 % of all maternal deaths were caused by HIV and
another 23 % by malaria [14]. The newest maternal mor-
tality trends from WHO, UNICEF, UNFPA and the
World Bank estimate that 13 % of maternal deaths in
Mozambique are attributable to AIDS-related indirect
maternal causes [3]. In an autopsy study of 139 maternal
deaths in Mozambique’s capital, Menéndez and coau-
thors reported that non-obstetric conditions accounted
for 56 % of deaths. In decreasing order of importance
were HIV/AIDS, bronchopneumonia, severe malaria and
meningitis. The primary obstetric cause of death was
hemorrhage. They also observed that the majority of
HIV/AIDS related maternal deaths were dying of under-
lying causes such as tuberculosis and Kaposi’s sarcoma
[15]. In a second paper using the same autopsy dataset
Ordi and coauthors found discrepancies between clinical
diagnoses and autopsy results in 40 % of maternal
deaths. They found not only a high rate of false negative
diagnoses for infectious diseases but also a high false
positive rate for eclampsia [16]. Where autopsies and
diagnostic tests are not routine, misclassification is a
common problem undermining the accuracy of causes
of maternal deaths [3]. Frequent misclassification errors
include epilepsy and eclampsia, cerebral malaria and
eclampsia, malaria and other febrile illnesses, and those
that surround abortion where deaths may be classified
as hemorrhage or sepsis [4, 17].
Malaria is endemic throughout the country and trans-
mission occurs throughout the year. It is the primary
cause of death in Mozambique and its impact on the
health system is heavy with 44 % of outpatient visits due
to malaria [14, 18]. Its negative impact on pregnancy
outcomes is well known, including maternal anemia, low
birth weight, fetal growth retardation, pre-term deliv-
ery, spontaneous abortion, stillbirth, and neonatal death
[19, 20]. The 2007 National Malaria Indicator Survey
observed that 18 % of pregnant women were positive
for malaria parasites and parasite density decreased as
parity increased, confirming a higher risk status (less
immunity) among women pregnant for the first time
[18]. In a large referral hospital in the capital of
Maputo, researchers found a significant relationship
between seasonality, maternal mortality and the role of
malaria. For three consecutive years (2001, 2002 and
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2003), malaria was the primary cause of maternal mor-
tality at this hospital [21].
Population-based national data on cause of maternal
death are lacking in most of sub-Saharan Africa and
elsewhere where the burden of maternal mortality is
high. Yet one of the principles guiding program planning
toward ending preventable maternal mortality is for
every country to understand the primary causes of
maternal death. Only then can the most appropriate
interventions be identified and prioritized [22]. Available
data tend to be based on subnational areas or single
facility data and commonly reflect institutional maternal
deaths only. Although the full demographic picture is
missing, as the percentage of births in facilities increases,
facility-based data will play an increasingly valuable role
in understanding the causes of maternal deaths.
The objectives of this descriptive paper are to describe
changes between 2007 and 2012 in the magnitude of
institutional maternal mortality, the causes of institu-
tional maternal deaths, and to highlight the extent to
which HIV, malaria and anemia contribute to maternal
mortality. Finally, we describe changes in the level of
facility where maternal deaths occurred and the public
health system’s availability of treatment for HIV infected
pregnant women as well as treatment and prevention of
episodes of malaria.
Methods
Two similar national cross-sectional surveys of health care
facilities conducted five years apart are the data sources
for this secondary data analysis. Table 1 summarizes key
aspects of the two surveys: the Needs Assessment in
Maternal and Neonatal Health in Mozambique, 2007–
2008 and the Needs Assessment for Emergency Obstetric
and Neonatal Care in Mozambique, 2012. Further infor-
mation about the methodology of the surveys can be
found in the final reports [2, 23].
Both surveys were designed to provide the Ministry of
Health and its partners with information for planning
and strategic decision-making; to assess progress on the
reduction of maternal mortality using indicators for
monitoring emergency obstetric care [24]; to provide
inputs for implementing interventions to reduce early
neonatal mortality, prevent unwanted pregnancies, and
to better understand the relationship between the avail-
ability of resources, quality of care and their impact on
maternal newborn morbidity and mortality. The 2007
assessment was designed to collect information on a
more ambitious range of topics, including investigating
facility capacity to repair obstetric fistula, availability of
maternity waiting homes, and interviews with service
users. The 2012 health facility survey had twice the sam-
ple size but a more limited substantive scope.
In both surveys the causes of maternal deaths that were
collected as part of the summary of service statistics were
defined by the parameters set out by WHO in the ICD-10
that allows for direct and indirect causes of maternal death
[3]. Some variation in the cause-of-death options occurred
across the two surveys. In 2007 all deaths were categorized
as falling into one of the following underlying causes of
death: antepartum or postpartum hemorrhage, prolonged
or obstructed labor, uterine rupture, postpartum sepsis,
severe pre-eclampsia, eclampsia, abortion complications,
ectopic pregnancy, other direct causes, HIV/AIDS, malaria
and other indirect causes. The questionnaire did not allow
for undetermined causes of death; it is likely that they were
assigned to either the “other direct” or “other indirect”
categories.
In 2012 the causes of death were virtually the same
except that retained placenta was added to the ques-
tionnaire (and in this analysis retained placenta was
combined with postpartum hemorrhage), and indirect
causes were broken down into the following mutually
exclusive categories: malaria, severe anemia, malaria +
severe anemia, HIV/AIDS, HIV/AIDS +malaria, HIV/
AIDS + anemia, other indirect causes, reflecting the
growing awareness of the high rates of co-infection and
co-morbidities. Finally, a category for unknown or
unspecified causes of death was added.
In both surveys, clinical definitions were covered dur-
ing the training of data collectors, all of whom had a
medical or public health background. Definitions of
severe obstetric complications could be found in the
2012 data collectors’ manual but were not included in
the 2007 manual. Data collectors were expected to
extract the cause of death from the registers and log-
books found in the facility. Diagnostic test results were
not a prerequisite for assigning cause of death, and we
do not know how many reported diagnoses were con-
firmed with diagnostic tests. No systematic physician
review of these causes of death took place in 2007 or
2012.
In addition to the service statistics, a maternal death
review (MDR) was a second source of information on
maternal deaths available only for 2007. It collected
demographic characteristics, obstetric history, and
details related to each woman’s clinical condition and
medical treatment. This module was completed for 712
of the 2,199 women identified in the summary of service
statistics. An MDR was completed for every maternal
death whose clinical records and files could be located
(see Table 3). Patient records were supplemented by
death reports performed by the Maternal Death Audit
Committee, if the cases were audited, and if case notes
and reports were available. At the end of the question-
naire, the data collector was given the opportunity to
reassign a cause of death only if their conclusion differed
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from that which was found in the patient’s records. All
MDRs were further reviewed by a team of physicians
before data entry; the final cause appears in Table 3. No
attempt was made to reconcile the cause of death as it
appeared in the MDR with that in the summary of
service statistics (see Table 2).
During the secondary data analysis, several questions in
the review were used to determine if any evidence existed
of HIV infection, malaria or anemia, and whether one or
more played a role in the woman’s condition. If one or
more of these questions below indicated that a woman
was HIV infected, had a diagnosis of malaria or anemia,
she was coded accordingly. Responses were pre-coded but
an optional “other” category existed and these “other”
responses were re-coded. The review questions were:
1. If the woman was referred, what were the reasons
for that referral?
2. Diagnosis on admission
3. After your review of the woman’s charts and
logbook data, what was the direct/indirect cause of
death?
4. If the woman suffered from an illness or medical
condition prior to the pregnancy, what was that
illness or condition?
The MDR data were not weighted since almost no
reviewed deaths occurred at the low level health centers
and posts. The health facility itself was the unit of analysis
for the assessment of the availability of infrastructure,
equipment and drugs.
This paper presents a descriptive comparison of the 2007
and 2012 data. Secondary analysis was performed using
Stata version 13 and SPSS version 17. For the 2007 data,
we show weighted and unweighted numbers, but rates or
percentages are based on weighted data, with the exception
of the MDR data as stated above. Weights were calculated
as the inverse of the probability of selection and adjusted
by facility non-response. The 95 % confidence intervals are
shown for the institutional MMR estimates in Table 2; all
figures for Table 2 were calculated within Stata and took
into account the weighting and provincial stratification. Al-
though some of the confidence intervals include a negative
integer, for practical purposes the lower bound was zero.
Table 1 Differences and similarities between the 2007 and 2012 national health facility assessments
2007–08 2012
Scope National National
Sampling All hospitals and health centers in district capitals; 40 %
stratified systematic random sample of lower level health
centers and posts; sampling frame restricted to facilities that
had attended at least one delivery in the last year n = 450
Census of all facilities that had attended at least one delivery
in the last year n = 946
Weighting Data required probability weighting to account for sampling
at lower level health centers and posts and adjusted for non-
response
Self-weighting
Data collectors Range of health professionals Medical students from the University of Eduardo Mondlane
Questionnaires Paper draws from 3 of 17 questionnaires: 1) summary of
service statistics for each facility, 2) maternal death reviews,
3) inventory of infrastructure, equipment, supplies and drugs
for maternal and neonatal health
Paper draws from 2 of 6 questionnaires (similar to those
used in 2007–08): 1) summary of service statistics, 2)
inventory of infrastructure, equipment, supplies and drugs.
These were adapted from AMDD tools [30]. Maternal death
reviews were not administered.
Primary sources of
data
Information on maternal deaths was collected from
maternity, postpartum and gynecology logbooks, operating
theatre, discharge and morgue registers, maternal death
reviews/audits. Data collectors also asked staff for other
facility-specific sources of information on maternal deaths.
Information on institutional deliveries was collected from the
relevant subset of registers. The use of monthly summaries






12 months (November 2006—October 2007). The number of
unweighted maternal deaths was 2,199, unweighted
institutional deliveries = 312,537.
3 months (August-October 2012). Number of maternal
deaths = 459, institutional deliveries = 161,986.
Overall data collection
period




National Committee for Bioethics in Health IRB 00002657,
Ministry of Health of Mozambique. All patient data were
de-identified and analyzed in the aggregate; no names
were collected.
Department of Reproductive, Child and Adolescent Health,
within the Mozambique Ministry of Health’s National
Directorate for the Promotion of Health and Disease Control.
Like 2007, no names or identifying characteristics of patients
were collected.
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These intervals should be considered informal testing as
the two datasets were not merged. The institutional mor-
tality ratios use as their numerator only deaths that
occurred after admission to the facilities surveyed, and the
denominator is based on the number of deliveries taking
place in the same facilities over the same 12 or three
month time period, depending on the survey.
The protocols for the primary data collection were
approved (see Table 1) by local entities but the current
secondary data analysis did not meet the regulatory def-
inition of research with human subjects per the U.S.
Code of Federal Regulations Title 45, Part 46.102(f ),
since the dataset obtained was completely de-identified.
Similarly, the use of informed consent was deemed
unnecessary for the secondary data analysis, however,
permission to use the data from the two surveys was
granted by the Ministry of Health’s National Directorate
for the Promotion of Health and Disease Control, by
UNFPA/Mozambique (a major funder of both surveys)
and the University of Eduardo Mondlane, the assessment
implementing partner in 2012.
Results
Magnitude of maternal mortality and changes in causes
of maternal death
Based on the summaries of service statistics for each
assessment, the institutional MMR declined by 47 %
between 2007 and 2012, from 541/100,000 births to 284/
100,000 (Table 2). In 2007, direct deaths were reported
to have been associated with 352 maternal deaths per
100,000 births versus 119 in 2012, a statistically signifi-
cant decline of 66 % (the two sets of 95 % confidence
intervals do not overlap). The decline among indirect
causes of maternal death was only 26 %, and not significant.
Cause-specific institutional MMRs declined by more than
50 % for all direct causes except for postpartum
hemorrhage and sepsis, and again, none was significant.
The categorization of specific indirect causes between 2007
Table 2 Number of weighted and unweighted institutional maternal deaths and overall and cause-specific institutional maternal
mortality ratios, by year
Deaths reported in 2007 (12 months of data) Deaths reported in 2012 (3 months of data)
n (unwt) n (wt) MMR per 100,000 birthsa 95 %
Confidence
Interval




Overall institutional MMR 2,199 2,596 541 364.7 718.3 459 284 168.6 400.0
Direct causes of death 1,450 1,689 352 231.0 473.1 192 119 63.5 174.4
Antepartum hemorrhage 113 133 28 15.8 40.3 19 12 4.8 18.8
Postpartum hemorrhage/at delivery 129 183 37 23.5 51.2 52 32 11.5 52.9
Severe pre-eclampsia/eclampsia 230 246 52 15.7 87.3 29 18 8.8 27.2
Prolonged/obstructed labor 158 212 44 22.4 66.4 21 13 −0.8 26.8
Uterine rupture 130 139 29 18.5 40.0 22 14 6.1 21.1
Sepsis 101 107 23 12.3 33.0 28 17 7.3 27.4
Ectopic pregnancy 86 86 18 −7.1 43.6 9 6 −1.1 12.3
Abortion 104 106 22 9.7 35.2 7 4 −2.0 10.6
Other direct causesb 399 476 113 58.5 166.6 5 3 0.0 6.2
Indirect causes 749 906 189 83.6 295.3 226 140 50.9 229.1
Malaria 196 240 56 1.9 109.7 63 39 −3.0 81.1
Malaria + anemia - - 27 17 −2.6 36.0
HIV 197 246 57 24.5 89.8 57 35 −11.4 82.0
HIV + anemia - - 8 5 −1.2 11.1
Malaria + HIV - - 16 10 −6.3 26.1
Anemia - - 34 21 9.8 32.3
Other indirect causesc 356 420 98 32.3 163.4 21 13 3.0 23.0
Unspecified/unknownd 41 25 2.6 48.2
a2007 unweighted number of institutional deliveries = 312,537, weighted = 478,308. 2012 required no weighting, number of institutional deliveries = 161,986
bIn 2012 other direct causes included suicide (rat poisoning), polyhydramnios, pyomyosites, complications from anesthesia or surgery
cIn 2012 other indirect causes included intoxication with tradtional medicines, asthma, pulmonary edema, respiratory insufficiency, meningitis,
meningoencephalitis, choked, brain tumor, hepatitis, cardiovascular disease, kidney failure
dIn 2007 unspecified or unknown causes of death were grouped with “other” direct or indirect causes.
wt = weighted; unwt = unweighted
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and 2012 changed, allowing combinations of causes to be
reported in 2012, and making comparisons between the
two surveys difficult. For example, if we combined maternal
deaths due to malaria alone, malaria + anemia, and eight of
the 16 malaria +HIV deaths (assuming we evenly split the
16 malaria +HIV deaths between malaria and HIV), and
compared this ratio with that of the single diagnosis of
malaria in 2007, the MMR for malaria changes from 56 to
60/100,000 deliveries. A similar exercise for HIV-related
deaths produces a decline from 57 to 45/100,000. Another
challenge is the large number of maternal deaths that ap-
pear as “other” direct and indirect causes in 2007. If these
two groups were reassigned to “unspecified causes” then
the decline in the direct institutional MMR would have
been 53 % (instead of 66 %) and the 26 % decline in the in-
direct MMR becomes an increase of 37 %. However, the
original categories are maintained rather than undermine
the integrity of the data, assuming that allocation to one
category over another was not arbitrary.
The primary obstetric cause of death in both years
was hemorrhage, combining antepartum and postpar-
tum hemorrhages (12 % of all deaths in 2007 and 15 %
in 2012). In 2007, 10 % of all maternal deaths were
attributed to HIV/AIDS and 9 % to malaria. In 2012,
because the categorization allowed multiple conditions
(malaria + anemia, HIV + anemia, malaria + HIV), the
comparison is not possible without double-counting.
Changes in location of deaths and births
Where women died in the hierarchy of the health system
changed over the five year interval: in 2007, 49 % of
maternal deaths took place in the largest urban hospitals
(central, general and provincial hospitals), 16 % in rural/
district hospitals, and 34 % in health centers and posts.
In 2012, this distribution shifted to 24 % of deaths taking
place in the largest urban hospitals and 41 % in rural/
district hospitals. The percentage of deaths occurring in
health centers/posts remained virtually the same (data
not shown). This shift took place after 15 health centers
were upgraded to the status of rural hospitals in 2012.
No shift in where births took place was observed: in
2007, 15 % of births took place in the largest urban hos-
pitals, 11 % in rural hospitals and 74 % in health centers
and posts. The distribution in 2012 was 13 %, 15 % and
72 %, respectively (data not shown).
Maternal death reviews and comorbidities
The 712 maternal death reviews, a subset (32 %) of the
2,199 deaths that occurred in 2007, allowed us to study in
detail selected characteristics of the women who did not
survive. A comparison of the two distributions of causes
of death (among all reported maternal deaths and all
deaths reviewed) suggests a larger proportion of direct
deaths (74 %) among the reviewed deaths than all reported
deaths (65 %). The MDRs reflect few “other” direct or
indirect causes and has a category for undetermined
causes. These aspects and the physician review in asses-
sing and assigning causes that was part of the MDR
process suggest a higher quality of reporting. However,
the 712 reviewed deaths may not be representative of the
2,199 total deaths. More than half (54 %) of the MDRs
were drawn from the most urban hospitals (central, gen-
eral or provincial hospitals), 28 % from rural hospitals and
18 % from health centers (data not shown). Comparing
this distribution to the 2,199 maternal deaths, the MDRs
under-represent the deaths occurring at health centers/
posts. This finding might reflect better record keeping and
more systematic death reviews or audits at higher level
facilities than at health centers and posts.
The differences between distributions, however, do not
diminish the objective of the analysis intended with this
table. Table 3 shows to what extent malaria, anemia, HIV
infection or any one of these three morbidities contributed
to the woman’s condition at death, for each reported cause
of death. The existence of these co-morbidities was deter-
mined by the four questions found in the review and
described in the methods section. Among women who
died of direct causes, malaria contributed to 13 % of cases,
anemia to 13 %, and HIV to 11 %, and evidence of any one
of the three co-morbidities was present for 30 % of the dir-
ect causes. These three categories were not mutually exclu-
sive, in other words, a woman who died of antepartum
hemorrhage could have been both HIV+ and anemic.
Several specific direct causes of death stand out as
having a large percentage of co-morbidity: 21 % of
deaths due to puerperal sepsis and 26 % of abortion
cases had evidence of HIV infection; 23 % of severe pre-
eclampsia/eclampsia cases and 26 % of abortion deaths
registered evidence of malaria; while anemia was impli-
cated in 38 % of the deaths due to ectopic pregnancy
and 24 % of abortion deaths. Evidence of HIV infection,
malaria and/or anemia was found among 56 % of the
abortion deaths.
Evidence of HIV infection, malaria and anemia were, by
definition, more prevalent among women who died of in-
direct deaths: evidence of HIV infection was documented
among 56 % of the 173 women who died of indirect
causes, malaria among 49 %, anemia among 19 %, and one
or more of the three co-morbidities was found in 89 % of
the cases. Among the 52 reported malaria deaths, HIV
infection contributed to 10 % and anemia to 14 %.
Mapping prevalence of HIV infection and malaria and
institutional maternal deaths where these infections
contributed
The percentage of MDRs with evidence of HIV infection
reported in each province mirrored the prevalence of
HIV infection among women ages 15–49 overall: lower
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percentages in the north where the prevalence of HIV
has been the lowest and higher percentages in the south,
Zambézia being the exception (Fig. 1). Despite an HIV
prevalence of 15 % in Zambézia, only 7 %, or 5 of 70
maternal death reviews reported HIV infection [25].
A reversed geographical pattern is seen with malaria
(Fig. 2), where the northern region had the highest preva-
lence of malaria among pregnant women (25 %) and the
highest percentage of case reviews with indications of mal-
aria (23 %). The south had the lowest malaria prevalence
(11.8 %) and also registered the smallest percentage of
maternal deaths where malaria was implicated (19.7 %),
though differences between the central and southern
regions were small [18].
Availability of treatment for HIV/AIDS and malaria
The two surveys did not focus on supplies used during
antenatal care so an assessment of the availability of im-
portant preventive measures such as insecticide treated
bednets (ITNs) or iron folate was limited. Nevertheless,
we were able to measure the percentage of health facil-
ities by type of facility that had certain antiretrovirals
and antimalarials in stock at the time of data collection
(Table 4). For all like items, greater availability at each
level of facility was observed in 2012 compared with
2007, but the increased availability at the health center/
post level was particularly dramatic. Additional drugs in
each category were captured as well, but they differed
between surveys.
Discussion
This paper triangulates three national datasets to de-
scribe the magnitude and causes of maternal mortality,
two datasets reflecting two points in time (2,199 and 459
maternal deaths in 2007 and 2012, respectively) that use
a similar methodology, and a third dataset that consisted
of 712 maternal death reviews, a subset of the 2,199
maternal deaths identified in the 2007 MNH assessment.
These datasets may contain the most comprehensive
information available to shed light on the evolution of
maternal mortality over the last decade.
During this five-year period, the findings of these two
sequential health facility assessments suggest that the
institutional MMR has declined by almost half, though
technically speaking, the 95 % confidence intervals do
overlap. The profile of institutional maternal mortality
may also be changing to one where proportionally fewer
maternal deaths are caused by obstetric complications
and a greater proportion is attributable to non-obstetric
causes. The declines among obstetric deaths were par-
ticularly noteworthy during the five-year interval. Data
collection methods preclude us from making similar
Table 3 Distribution of 2007 causes of death according to data source and percent of maternal death reviews for which malaria,
anemia, HIV infection, or any one of the three morbidities contributed to the woman’s condition
Maternal deaths reported in service statistics Maternal deaths reviewed Malaria Anemia HIV Any 1 of 3
n % (wt) n % % % % %
Total 2,199 100 712 100 21 14 22 44
Direct causes 1,450 65 528 74 13 13 11 30
Antepartum hemorrhage 113 5 37 5 5 19 14 30
Postpartum hemorrhage 129 7 101 14 7 13 10 25
Severe pre-eclampsia/eclampsia 230 10 91 13 23 3 13 33
Prolonged/obstructed labor 158 8 23 13 17 0 4 22
Uterine rupture 130 5 116 16 3 9 2 13
Sepsis 101 4 80 11 16 19 21 41
Ectopic pregnancy 86 3 21 3 14 38 0 43
Abortion 104 4 50 7 26 24 26 56
Other direct causes 399 19 9 1 11 11 0 22
Indirect causes 749 35 173 24 49 19 56 89
Malaria 196 9 52 7 100 14 10 100
HIV 197 10 76 11 24 15 100 100
HIV + Malaria - - 10 1 100 10 100 100
Anemia - - 13 2 15 100 31 100
Embolism - - 7 1 0 14 0 14
Other indirect causes 356 17 15 2 13 0 13 13
Causes unknown 11 2 0 9 0 9
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conclusions about declines among indirect causes of
death. Meanwhile the MDRs revealed how frequently
HIV infection, malaria and anemia were associated with
women dying of obstetric causes. Health system efforts
to reduce direct obstetric deaths may be succeeding as
are efforts to increase institutional births, both of which
are meaningful achievements.
This study complements the work by Singh et al. that
drew from the 2007–08 INCAM study of deaths that
occurred in 2006–07, a similar timeframe as the deaths
in the 2007 MNH assessment [15]. Forty-three percent
of the maternal deaths identified in the post-census
study died within health care facilities [14], some of
whom probably were counted in the 2007 MNH assess-
ment. Table 5 summarizes the breakdown between dir-
ect causes of death and the primary non-obstetric causes
for the different national data collection efforts. These
sources point to the sizeable contribution that these two
infectious diseases make on maternal mortality.
Based on the 2007 MDRs and responses to ancillary
questions, HIV infection, malaria and/or anemia contrib-
uted to 44 % of the maternal deaths, if not as primary
causes, as co-morbidities. By focusing on the prevention
and treatment of selected obstetric causes (postpartum
hemorrhage, severe pre-eclampsia and eclampsia, and
prolonged and obstructed labor/uterine rupture) as well
Fig. 1 Map of maternal death reviews, with HIV implicated, 2007
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as these three co-morbidities, the burden of maternal
mortality in Mozambique could be significantly
reduced. The integration of HIV and malaria services
into reproductive health services, especially through the
platform of antenatal care, has the scope for improving
maternal and fetal/newborn outcomes. The shift
towards more non-obstetric causes of death makes the
target number and quality of antenatal visits all the
more critical. It also raises cautionary concerns about
overloading providers of antenatal care, the need for
additional time and skills for different tests, educational
messages, and the need for sufficient staffing, equip-
ment and supplies.
Program recommendations
HIV counseling, testing and antiretroviral therapy for
HIV infected pregnant women is one such package of
services, with strong evidence of the protective effect of
antiretroviral therapy (ART) for HIV+ pregnant women,
especially if they initiate therapy before pregnancy [26].
It is not clear how much effect ART is likely to have had
in 2007 as the WHO guidelines for ART and improving
maternal survival were not issued until 2010.
Where malaria transmission is stable and high, WHO
has endorsed intermittent presumptive therapy (IPTp)
with at least two doses of sulfadoxine-pyrimethamine
(SP) during pregnancy and the use of insecticide-treated
Fig. 2 Map of maternal death reviews, with malaria implicated, 2007
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bednets for pregnant women [27]. Iron-folate supple-
mentation for 90 days is also recommended. The
Mozambican national policy for malaria in pregnancy
stipulates three doses of SP and each is taken under ob-
servation during antenatal care. The 2011 Demographic
Health Survey and the 2007 Malaria Indicator Survey in-
dicate gaps in coverage and the quality of these services
[11, 18]. Using mixed methods, Boene and colleagues
looked at the acceptability of bednets and SP and found
that bednets were the preventive intervention of choice,
but they also found that women’s awareness of the
adverse consequences of malaria in pregnancy especially
for the fetus or newborn was low [28].
This paper also presents evidence of an increase in the
availability of antimalarials and antiretrovirals, especially
at the health center/post level, which should translate
into greater access, utilization and protection. From the
2011 Mozambique Demographic and Health Survey, we
know that 34 % of pregnant women slept under an in-
secticide treated bednet, 40 % of women with a live birth
in the two years before the survey took antimalarials
during the pregnancy, and 19 % received IPTp [11].
Given the finding in this study of no apparent decline in
reported malaria deaths, it is possible that utilization of
these protective measures had not increased sufficiently
to have been measurable in 2012. Subsequent rounds of
household surveys may shed light on the extent to which
utilization has increased.
HIV and direct obstetric complications
Some of our descriptive findings are in agreement with
the literature on the relationship between HIV infection
and the risk of direct obstetric complications. Two
mechanisms of action may be at work: first, a biological
increase in susceptibility due to immunosuppression but
also social discrimination that could drive a delay in
accessing facility-based care. Calvert and Ronsmans
found that HIV infected pregnant women had more than
three times the odds of developing puerperal sepsis com-
pared with uninfected women [9]. Among the MDRs we
also found a high percentage (21 %) of the 80 deaths due
to sepsis were HIV-infected women while as many as
41 % reported signs of HIV, malaria, or anemia. Invasive
non-typhoidal Salmonella infection is also associated
Table 4 Percentage of facilities with drugs in stock for HIV and malaria, by type of facility and year
Central, Provincial & General Hospitals Rural & District Hospitals Health Centers & Posts Total
2007 2012 2007 2012 2007 2012 2007 2012
n = 16 n = 14 n = 26 n = 41a n = 347 n = 891 n = 389 n = 946
% (wt) % % (wt) % % (wt) % % (wt) %
Antiretrovirals
Nevirapine 71 93 74 93 23 88 26 88
AZT 65 100 74 83 20 81 23 81
3TC + AZT/D4T 71 na 73 na 18 na 21 na
3TC na 86 na 73 na 59 na 60
Antimalarials
Artemether + Lumefantrine (Coartem) 81 86 87 90 18 86 22 86
Quinine (inj) 74 100 54 85 22 70 24 71
Quinine (oral) 70 100 47 88 12 63 14 64
Artesunate na 29 na 5 na 7 na 7
SP (IPTp) 94 na 83 na 32 na 35 na
AZT zidovudine, 3TC lamivudine, D4T stavudine, SP sulfadoxine-pyrimethamine (Fansidar), IPTp intermittent presumptive treatment during pregnancy, na not
applicable, inj injection, wt weighted
a15 health centers in 2007 were reclassified as rural hospitals by 2012
Table 5 Summary of causes of death by data source
Data Source No. of maternal deaths Direct causes HIV-related Malaria-related Other indirect Unknown
2007–08 INCAM 213 55 % 18 % 23 % 4 % –
2007 MNH assessment 2,199 65 % 10 % 9 % 17 % –
2007 MDRs 712 74 % 12%a 7 % 5 % 2 %
2012 EmONC assessment 459 42 % 17%b 20 % 12 % 9 %
a1 % of the MDR deaths were attributed to malaria + HIV and were included with HIV deaths
b3 % of 2012 deaths were attributed to malaria + HIV and are included with HIV deaths
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with HIV, malaria and anemia, but often goes undiagnosed
and may explain some of these findings. A similarly high
proportion (43 %) of deaths due to ectopic pregnancy also
reported signs of HIV, malaria, or anemia.
Among the MDRs were 50 deaths attributed to abortion
and more than half also suffered from HIV infection,
malaria, or anemia, all of which have a plausible biological
mechanism of action. The data do not allow us to dis-
tinguish spontaneous pregnancy losses from attempts
to terminate a pregnancy. Pressure to prevent pregnan-
cies with contraceptive methods among HIV+ women
has been observed in Mozambique [29]. The authors
also found that the desire for pregnancy among HIV+
women was often strong. A healthy pregnancy in an
HIV+ woman can be supported with IPTp, bednets,
antimalarials, antiretrovirals, and iron folate for anemia.
Limitations
Several limitations to this study should be noted. Some
are challenges common to using secondary data designed
for other purposes but also are common to studying
causes of maternal mortality, especially at this scale –
problems of sample size, validity as well as comparability.
A certain amount of caution should be exercised when
interpreting cause-specific changes over time. Assigning
cause of death was dependent on accessible written
records found in the facility and not necessarily driven by
laboratory based diagnoses or autopsy reports, affecting
both obstetric and non-obstetric causes. Comparability
among indirect causes was hampered by changes in the
data collection forms. The MDRs in 2007 may have more
accurate diagnoses but we do not know how well they rep-
resent the deaths who were not reviewed. Health workers
experience difficulties with coding and death certificate
completion, and with the misclassification of maternal vs.
non-maternal deaths, as well as specific causes. Identifica-
tion of maternal deaths can be obstructed especially if
there is no relationship of trust between unknown data
collectors and health workers. Identifying indirect deaths
is particularly difficult in these assessments since these
women usually do not die in the maternity wing and the
focus of the assessments was clearly on obstetrics and
childbirth. Data collector fatigue is a common problem,
data collectors may fail to request help due to concern
about interrupting services and making demands on
health workers, and they feel pressure to move on to the
next facility. The careful review that might be expected at
a single facility is difficult to sustain over hundreds of
facilities. To minimize some of these sources of bias, data
collectors were trained to be non-judgmental and to seek
out multiple sources of information for facility deaths—to
ask about facility specific sources, autopsy reports, mortu-
ary logbooks, operating theatres, ob/gyn registries, and
admission and discharge registries. Nevertheless, the
categorization in 2007 of 19 % as “other direct” deaths and
17 % as “other indirect” deaths are indications of a lost
opportunity to better inform programmatic efforts for
maternal and newborn health. During this secondary data
analysis the original 2007 questionnaires were not avail-
able, and these “other” deaths could not be explored.
Women whose cause of death was unknown were likely
to have been placed in these categories as were women
with competing multiple causes, such as an obstetric and
a non-obstetric cause of death. It is also highly likely that
the “other” indirect deaths include cases of tuberculosis,
hepatitis, pneumonia, cardiovascular disease, diabetes and
other relatively common indirect causes.
Another concern for comparability derives from the dif-
ferent data collection periods. The 2007 assessment col-
lected deaths over a period of 12 consecutive months. In
2012, the summary statistics were drawn from a period of
only three consecutive months—August, September and
October. We know that malaria-related deaths in
Mozambique are seasonal, with peaks during and after the
rainy season, which is October through March [21, 28].
According to Romagosa et al., the primary peak in
Maputo is April, followed by a peak in October. In 2012,
106 maternal deaths were to women with signs of malaria
and 58 % occurred in the month of October, suggesting
that the data collection period included at least one of
those peaks. However, it is possible that the three months
of maternal deaths were not representative of those that
would have occurred over a 12-month period.
Methodological issues
For a complete understanding of the epidemiology of ma-
ternal death, the public health community aspires to
population-based studies of the causes of maternal death,
but as the percentage of births delivering in facilities
increases, facility-based studies become more useful. In
fact, the most recent systematic review of maternal deaths
included facility-based distributions of causes of maternal
deaths if at least 50 % of births were institutional [4]. The
2011 Mozambique Demographic and Health Survey found
that 55 % of deliveries were conducted in facilities [11],
while the 2012 EmONC assessment estimated an institu-
tional delivery rate closer to 70 %, albeit using different
methodologies [2]. Nevertheless, the institutional ratios
can be helpful to program managers and clinicians in
identification and prioritization of morbidities that health
workers must be competent and equipped to treat or
refer.
By measuring the magnitude of institutional maternal
mortality with the maternal mortality ratio inevitably
leads to a comparison between the institutional MMR
and the population-based MMR. But they are not readily
comparable given different measurement methodologies,
sources of data, and the selection bias inherent among
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women who seek health care services in facilities. The
2013 MMR as measured by WHO, UNICEF, UNFPA, the
World Bank and the United Nations Population Division
was 480/100,000 births, substantially higher than the 2012
institutional MMR of 284. The higher figure is the result
of multi-level regression modeling that takes into consid-
eration an incomplete civil registration system and other
types of data, and estimates separately the proportion of
AIDS deaths that qualify as indirect deaths [3]. The 2012
institutional figure of 284 is likely to be low as we know
that the three-month time period on which it was based
failed to include the peak month of malaria deaths. Also,
we can assume that maternal deaths were missed by the
facility assessment. An important unknown is how many
maternal deaths continue to take place outside health care
facilities. According to the INCAM data of 2007, only
43 % of all maternal deaths occurred within health care
facilities. Given the increase in institutional deliveries
since 2007, it is possible that more deaths occur in facil-
ities than in the community. The increase in institutional
delivery is also likely to affect the patient profile, perhaps
lowering the risk profile as more women experiencing a
routine delivery seek services. This would translate into an
increasing denominator for the institutional ratio. The
next Mozambique Demographic and Health Survey,
assuming it measures maternal mortality, will produce yet
another population-based estimate that may confirm an
MMR lower than the 2011 DHS estimate of 400.
In recognition of the growing importance of indirect
causes of maternal mortality, the indicator “proportion
of institutional maternal deaths due to indirect causes”
was added in 2009 to a widely used set of indicators for
monitoring emergency obstetric care and promoted by
the UN agencies [24]. The rationale behind this indicator
was first, to draw attention to the rising need for inter-
ventions in addition to emergency obstetric care, and
second, to monitor the shift towards increasing indirect
deaths as obstetric causes decline. However, as the
research on the intersection between maternal mortality
and HIV infection suggests, the term indirect may be
less helpful than distinguishing between obstetric and
non-obstetric causes or between deaths “with HIV” and
deaths “from HIV.” The same could be said for malaria-
related deaths.
Conclusions
Mozambique’s pregnant women face multiple risks in an
environment of high prevalence of HIV and malaria and
where access to services can be a challenge. There are
encouraging signs that institutional maternal mortality is
decreasing, but infectious diseases are a larger propor-
tion of the deaths. Moving forward, HIV and malaria
prevention/treatment should be further integrated into
maternal and child health platforms such as antenatal
care, but with the necessary system support. In addition
to looking at population level data sources when avail-
able, access to facility-based information on maternal
causes of death is relatively easy and invaluable—and
more countries should take advantage of this informa-
tion readily at hand as well as implement maternal death
reviews—as a means to prioritizing interventions needed
to end preventable maternal and newborn deaths.
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